P4‐253: THE CRITICAL PATH FOR ALZHEIMER'S DISEASE (CPAD) CONSORTIUM – A PRE‐COMPETITIVE, GLOBAL, INTEGRATED, AND STANDARDIZED ALZHEIMER DISEASE CLINICAL TRIAL DATA SHARING REPOSITORY TO SUPPORT AD DRUG DEVELOPMENT. (1st July 2019)